AccurKardia has gained the US Food and Drug Administration's (FDA) breakthrough device designation for its AI-powered ‘AK+ ...

AccurKardia announced that it received FDA breakthrough device designation for its ECG-based, AI-powered hyperkalemia ...

AccurKardia, an innovator in ECG-based diagnostics technology, has announced that it has received Breakthrough Device ...

Objective To compare long-term survival, reinterventions and risk factors using strict definitions of neonatal critical and non-critical valvular aortic stenosis (VAS). Design A nationwide ...

Narrowing of this valve, known as aortic stenosis, impacts blood flow out of the heart. More than 13% of older adults have aortic stenosis. Aortic regurgitation, on the other hand, is leakiness of ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

In conclusion, the TCW trial provides crucial insights, highlighting the potential of TAVI combined with FFR-guided PCI as a transformative, less invasive treatment for patients with severe aortic ...

A tragic case in Canada has raised concerns about the country's healthcare system after Adam Burgoyne, 39, died from an aortic aneurysm following an unsuccessful hospital visit. On December 6 ...

We present a case of a 76-year-old patient with concomitant severe aortic valve stenosis and severe mitral valve stenosis who underwent concurrent ... and there was no change in the PR interval or QRS ...

With FDA approval in the bag for its AI-based aortic stenosis diagnostic tool, Echo IQ is focused on commercialisation over ... Read More The post Dr Boreham’s Crucible: Can this aortic stenosis ...